|
我国艾滋病人整体病死率降了64%
来源：健康报 2011年05月26日08:09我
本报讯 （记者郑灵巧）实施免费抗艾滋病病毒治疗7年间，中国艾滋病患者（包括治疗和未治疗人群）整体病死率下降64%。未接受抗病毒治疗是艾滋病病人死亡最主要风险因素，已接受抗病毒治疗人群死亡最主要风险因素是发现治疗过晚免疫细胞CD4
由中国疾控中心性病艾滋病预防控制中心治疗关怀室完成的上述研究，分析了2002年～2009年中国抗病毒治疗工作情况。在截至2009年全国累计报告的323252名艾滋病病毒感染者和病人中，145484人符合抗病毒治疗标准，免疫细胞CD4平均为194/微升。在几乎没有抗病毒治疗的2002年，总体病死率为39.3/百人年，2009年降至14.2/百人年（包括治疗和未治疗人群）；接受治疗的患者病死率为5.7/百人年，治疗覆盖率几乎从0增至63.4%。到2009年，静脉吸毒、性传播和卖血浆3种途径感染人群病死率分别为15.9/百人年、17.5/百人年和6.7/百人年，治疗覆盖率分别是42.7%、61.7%和80.2%。
据该治疗关怀室主任张福杰教授介绍，研究还发现，在静脉吸毒感染人群中，接受美沙酮替代治疗者与未接受者相比，抗病毒治疗覆盖率显著居高，病死率显著降低。
张福杰称，目前我国艾滋病病毒感染者治疗覆盖率和死亡率与发达国家相比还有一定差距，除医疗水平和资源方面原因外，可能与我国感染者发现、诊断和治疗过晚有关。我国感染者首次确诊时CD4计数平均为201/微升，大部分已是艾滋病病人，过去几年接受治疗的病人约有30%的人CD4≤50/微升。2010年美国抗病毒治疗指南推荐，当CD4≤500/微升时即应开始治疗。
艾滋病不治会早死，早治才康复 艾滋病不治会早死，早治才康复 艾滋病不治会早死，早治才康复 艾滋病不治会早死，早治才康复
 |
| 图示∶2011年5月正式出版的《中国特色医疗金鉴》登载的刘君主任及其机构事迹 |
| |
|
|
The overall mortality rate of AIDS dropped by 64%
Source: Health News at 08:09 on May 26, 2011 I
(Reporter Zheng smart) the introduction of free anti-HIV for 7 years, the China AIDS patients (including treatment and untreated groups) 64% decline in overall mortality. Not receiving antiretroviral therapy is the most important risk factors of death of AIDS patients, people receiving antiretroviral treatment has been the most important risk factor for death was found late treatment of CD4 immune cells
By the Chinese Center for Disease Control and Prevention of STD and AIDS care treatment rooms complete the study, analyzed the 2002 to 2009 the work of antiretroviral therapy in China. As of 2009, in the report of the national total of 323,252 HIV infected people and patients, antiviral therapy 145 484 met the criteria, an average of 194 CD4 immune cells / μL. Almost no anti-viral treatment in 2002, the overall mortality rate was 39.3 / million person-years in 2009 to 14.2 / million person-years (including treatment and untreated groups); mortality of patients treated was 5.7 / million person-years, treatment coverage rate almost from 0 to 63.4%. By 2009, intravenous drug use, sexual transmission and sale of plasma HIV infections among 3 Mortality was 15.9 / million person-years, 17.5 / million person years and 6.7 / million person-years, treatment coverage was 42.7%, respectively, 61.7% and 80.2%.
According to the treatment of Professor Zhang Fujie, director of care introduced, the study also found that intravenous drug users in the crowd, receiving methadone substitution treatment, compared with no recipients, antiviral therapy was significantly high in coverage, mortality was significantly reduced.
Zhang Fujie said the current treatment of HIV infection and mortality coverage still lags far behind the developed countries, in addition to medical standards and resource reasons, China may be infected with the detection, diagnosis and treatment of late on. The time of diagnosis of infection for the first time the average CD4 count of 201 / ul, is most AIDS patients receiving treatment the past few years about 30% of the patients were CD4 ≤ 50 / slightly. 2010 U.S. guidelines recommend antiretroviral therapy when CD4 ≤ 500 / slightly when treatment should begin.
|
